Literature DB >> 19244113

Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.

R Matthew Klein1, Andrew E Aplin.   

Abstract

The depth of cell invasion into the dermis is a clinical determinant for poor prognosis in cutaneous melanoma. The signaling events that promote the switch from a noninvasive to invasive tumor phenotype remain obscure. Activating mutations in the serine/threonine kinase B-RAF are prevalent in melanoma. Mutant B-RAF is required for melanoma cell invasion. The expression of Rnd3, a Rho family GTPase, is regulated by mutant B-RAF, although its role in melanoma progression is unknown. In this study, we determined the functional contribution of Rnd3 to invasive melanoma. Endogenous Rnd3 was targeted for knockdown using a doxycycline-inducible short hairpin RNA system in invasive human melanoma cells. Depletion of Rnd3 promoted prominent actin stress fibers and enlarged focal adhesions. Mechanistically, stress fiber formation induced by Rnd3 knockdown required the specific involvement of RhoA and ROCK1/2 activity but not RhoB or RhoC. Rnd3 expression in human melanoma cell lines was strongly associated with elevated extracellular signal-regulated kinase phosphorylation and invasive behavior in a three-dimensional dermal-like environment. A functional role for Rnd3 was shown in the invasive outgrowth of melanoma tumor spheroids. Knockdown of Rnd3 reduced the invasive outgrowth of spheroids embedded in collagen gels. Additionally, Rnd3 depletion inhibited collective and border cell movement out from spheroids in a ROCK1/2-dependent manner. Collectively, these findings implicate Rnd3 as a major suppressor of RhoA-mediated actin cytoskeletal organization and in the acquisition of an invasive melanoma phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244113      PMCID: PMC2657934          DOI: 10.1158/0008-5472.CAN-08-3201

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  RhoE inhibits cell cycle progression and Ras-induced transformation.

Authors:  Priam Villalonga; Rosa M Guasch; Kirsi Riento; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 2.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

3.  A pancreatic cancer-specific expression profile.

Authors:  T M Gress; F Müller-Pillasch; M Geng; F Zimmerhackl; G Zehetner; H Friess; M Büchler; G Adler; H Lehrach
Journal:  Oncogene       Date:  1996-10-17       Impact factor: 9.867

4.  A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.

Authors:  Lei Wang; Linda Yang; Yongneng Luo; Yi Zheng
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

5.  Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.

Authors:  Hidetoshi Sumimoto; Makoto Miyagishi; Hiroyuki Miyoshi; Shizuko Yamagata; Ayako Shimizu; Kazunari Taira; Yutaka Kawakami
Journal:  Oncogene       Date:  2004-08-12       Impact factor: 9.867

6.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility.

Authors:  Emmanuel Vial; Erik Sahai; Christopher J Marshall
Journal:  Cancer Cell       Date:  2003-07       Impact factor: 31.743

7.  Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

Authors:  Marion M Schuierer; Frauke Bataille; Suzanne Hagan; Walter Kolch; Anja-Katrin Bosserhoff
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

8.  Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.

Authors:  Jonathan T Huntington; Janiel M Shields; Channing J Der; Colby A Wyatt; Ulrike Benbow; Craig L Slingluff; Constance E Brinckerhoff
Journal:  J Biol Chem       Date:  2004-06-07       Impact factor: 5.157

9.  Rho GTPases have diverse effects on the organization of the actin filament system.

Authors:  Pontus Aspenström; Asa Fransson; Jan Saras
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

10.  Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure.

Authors:  David Komander; Ritu Garg; Paul T C Wan; Anne J Ridley; David Barford
Journal:  EMBO J       Date:  2008-10-23       Impact factor: 11.598

View more
  43 in total

Review 1.  Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma.

Authors:  Inna V Fedorenko; Kim H T Paraiso; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2011-05-25       Impact factor: 5.858

Review 2.  A brief history of melanoma: from mummies to mutations.

Authors:  Vito W Rebecca; Vernon K Sondak; Keiran S M Smalley
Journal:  Melanoma Res       Date:  2012-04       Impact factor: 3.599

Review 3.  Pathophysiological Functions of Rnd3/RhoE.

Authors:  Wei Jie; Kelsey C Andrade; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jiang Chang
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression.

Authors:  Manali S Phadke; Patrizia Sini; Keiran S M Smalley
Journal:  Mol Cancer Ther       Date:  2015-04-14       Impact factor: 6.261

Review 5.  Unravelling the complexity of metastasis - molecular understanding and targeted therapies.

Authors:  Nilay Sethi; Yibin Kang
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

6.  ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.

Authors:  Meagan B Ryan; Alexander J Finn; Katherine H Pedone; Nancy E Thomas; Channing J Der; Adrienne D Cox
Journal:  Mol Cancer Res       Date:  2016-07-14       Impact factor: 5.852

7.  Genetic deletion of Rnd3/RhoE results in mouse heart calcium leakage through upregulation of protein kinase A signaling.

Authors:  Xiangsheng Yang; Tiannan Wang; Xi Lin; Xiaojing Yue; Qiongling Wang; Guoliang Wang; Qin Fu; Xun Ai; David Y Chiang; Christina Y Miyake; Xander H T Wehrens; Jiang Chang
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

8.  Phosphoproteomic analysis of basal and therapy-induced adaptive signaling networks in BRAF and NRAS mutant melanoma.

Authors:  Inna V Fedorenko; Bin Fang; Ana Cecelia Munko; Geoffrey T Gibney; John M Koomen; Keiran S M Smalley
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

9.  TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Authors:  Michele B Weiss; Ethan V Abel; Melanie M Mayberry; Kevin J Basile; Adam C Berger; Andrew E Aplin
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

Review 10.  Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma.

Authors:  Geoffrey T Gibney; Jane L Messina; Inna V Fedorenko; Vernon K Sondak; Keiran S M Smalley
Journal:  Nat Rev Clin Oncol       Date:  2013-05-28       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.